Wai Chun Bio-Technology Ltd. (HK:0660) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Wai Chun Bio-Technology Limited has announced a potential delay in the release of its annual results due to the resignation of its Chief Financial Officer, which has caused difficulties in providing necessary information for audit completion. As a result, the company is also postponing its Board Meeting while it works to finalize the audit with its auditors. The new dates for the publication of the results and the rescheduled Board Meeting will be communicated in due course.
For further insights into HK:0660 stock, check out TipRanks’ Stock Analysis page.